Position history for FARALLON CAPITAL MANAGEMENT LLC's holdings in CENTESSA PHARMACEUTICALS PLC
FARALLON CAPITAL MANAGEMENT LLC holds 4.8M shares of CNTA (CENTESSA PHARMACEUTICALS PLC), worth $191M as of 2026-Q1. The position was decreased (-10.6% shares). CNTA represents 1.1% of FARALLON CAPITAL MANAGEMENT LLC's portfolio.
Current Value
$191M
Current Shares
4.8M
Total Value Change
+$173M
Total Shares Change
+2.8M
Other major holders of CNTA: Avoro Capital Advisors LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., Pentwater Capital Management LP
Decreased |
| 4.8M |
-10.6% |
| $191M |
| 1.1% |
| $26.20 |
0 |
| 2025-Q4 | Increased | 5.4M | +24.1% | $134.5M | 0.6% | $24.74 | 52 |
| 2025-Q3 | Decreased | 4.3M | -4.4% | $105M | 0.4% | $24.40 | 0 |
| 2025-Q2 | Increased | 4.5M | +4.5% | $59.5M | 0.3% | $13.13 | 37 |
| 2025-Q1 | Increased | 4.3M | +23.9% | $62.3M | 0.3% | $14.59 | 43 |
| 2024-Q4 | Increased | 3.5M | +24.3% | $58.6M | 0.3% | $16.35 | 43 |
| 2024-Q3 | Increased | 2.8M | +41.0% | $45M | 0.2% | $15.79 | 46 |
| 2024-Q2 | Increased | 2M | +438.0% | $18M | 0.1% | $9.03 | 46 |